Complex Generics & the Prescription Drug Landscape Many American adults--nearly 60 million, according to some recent consumer surveys--have difficulty affording their prescription drug medicines even with insurance, putting their health and financial priorities at odds. Complex generics have the potential to generate significant savings for patients and the health care system. But market dynamics and regulatory complexities are seen as significant hurdles. Join The Hill's Steve Clemons for a discussion with leading medical voices, policy experts, and members of Congress to discuss how complex generic medical alternatives can impact and potentially enhance the American healthcare system. Featured speakers: Rep. Brett Guthrie (R-KY), Ranking Member, Energy and Commerce Committee Subcommittee on Health Rep. Peter Welch (D-VT), Co-Chair and Founder, Congressional Affordable Medicines Caucus Tammy Boyd, Chief Policy Officer & Counsel, Black Women's Health Imperative Alex Brill, Founder and CEO, Matrix Global Advisors; Resident Fellow, American Enterprise Institute Dr. Sally Choe, Director, Office of Generic Drugs, FDA Rep. Brett Guthrie (R-KY), Ranking Member, Energy and Commerce Committee Subcommittee on Health Dr. Kashyap Patel, CEO, Carolina Blood and Cancer Care Rep. Peter Welch (D-VT), Co-Chair and Founder, Congressional Affordable Medicines Caucus Tonya Winders, President and CEO, Allergy & Asthma Network RSVP Today! 1:00 PM ET / 10:00 AM PT Tuesday, February 9th Questions for our speakers? Join the conversation using @TheHillEvents and #TheHillRx. |
No comments:
Post a Comment